ADVIA CENTAUR XP PROGESTERONE (PRGE) N/A 10310305

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2017-01-10 for ADVIA CENTAUR XP PROGESTERONE (PRGE) N/A 10310305 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[64429796] An mdr was not initially filed for this complaint as no injury was described. A progesterone measurement of 0. 63 ng/ml when 0 ng/ml in most instances is not considered clinically significant as both measurements are either within or below the expected reference interval depending on timing of the test. Siemens investigated cross-reactivity of dhea-s in the advia centaur xp progesterone assay, dimension vista loci progesterone assay, immulite/immulite 1000 progesterone assay and immulite 2000 progesterone assay and confirmed that dhea-s may cause elevated progesterone results in these assays. Dhea-s may be used as part of an ivf treatment plan for patients who are also being considered for fresh embryo transfer. A falsely elevated progesterone result around the clinical decision threshold of approximately 1. 0 ng/ml may lead to misinterpretation of progesterone levels and consideration of fresh embryo transfer cancellation and subsequent cryopreservation of the embryo(s). Siemens distributed urgent medical device correction cc 17-06. A. Us to customers in the united states and urgent field safety notice cc 17-06. A. Ous to customers outside the united states on january 4, 2017. These communications notify customers of the crossreactivity of dhea-s in the assays and advise customers to use an alternate method such as liquid chromatography-mass spectrometry (lc-ms) when measuring progesterone in patients using dhea-s supplements. No further investigation is required.
Patient Sequence No: 1, Text Type: N, H10


[64429797] Customer contacted siemens requesting information regarding cross-reactivity of dhea-s with the advia centaur xp progesterone assay. The customer noted that there have been elevated progesterone results from patients who were taking dhea-s the customer reported that some doctors have taken their patients off of dhea-s. There are no reports of adverse health consequences due to the elevated advia centaur xp progesterone results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2016-00273
MDR Report Key6238212
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2017-01-10
Date of Report2017-01-10
Date of Event2015-12-21
Date Mfgr Received2015-12-21
Date Added to Maude2017-01-10
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLOUISE MCLAUGHLIN
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604381
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Remedial ActionRC
Previous Use Code3
Removal Correction Number1219913-01/04/2017-001-C
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP PROGESTERONE (PRGE)
Generic NamePROGESTERONE IMMUNOASSAY
Product CodeJLS
Date Received2017-01-10
Model NumberN/A
Catalog Number10310305
Lot Number273
Device Expiration Date2016-08-28
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2017-01-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.